AAV5-S100A1

Dorothea Kehr1,2,3, Janek Salatzki2, Birgit Seger1,2

  • 1Division of Molecular and Translational Cardiology (D.K., B.S., K.V., J.B., A.J., M.B., J. Ritterhoff, P.M.), University Hospital Heidelberg, Germany.

PubMed
概括

腺相关病毒5 (AAV5) 在人体尺寸模型中有效地将基因传递给健康和功能障碍的心脏. 这种基因疗法对治疗心力衰竭具有长期安全性和有效性的承诺.